| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.01 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.01 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |